TP53 and hepatocellular carcinoma: 0404 up-regulates miR-34a and increased p53 acetylation in both in vitro and HepG2-bearing nude mice, suggesting that its anti-tumoral activity on HCC was exerted via p53/miR-34a/SIRT1 pathway [119].